Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Membranous Nephropathy
Related studies linked through entity extraction aliases.
Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NEPTUNE Match Study
- Status
- RECRUITING
- Phase
- NA
Immunopathological Analysis in a French National Cohort of Membranous Nephropathy
- Status
- UNKNOWN
- Phase
- NA
A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Autoreactive B Cells in Membranous Nephropathy
- Status
- RECRUITING
- Phase
- N/A
Belimumab With Rituximab for Primary Membranous Nephropathy
- Status
- RECRUITING
- Phase
- PHASE2
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
- Status
- RECRUITING
- Phase
- N/A
Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
- Status
- COMPLETED
- Phase
- PHASE2
Adrenocorticotropic Hormone in Membranous Nephropathy
- Status
- COMPLETED
- Phase
- PHASE4
Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy
- Status
- COMPLETED
- Phase
- NA
Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
- Status
- COMPLETED
- Phase
- PHASE3
Nephrotic Syndrome Study Network
- Status
- RECRUITING
- Phase
- N/A
The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
- Status
- COMPLETED
- Phase
- NA
To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)
- Status
- COMPLETED
- Phase
- PHASE4
Rituximab in Membranous Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1